XML 25 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flow from operating activities:    
Net loss $ (10,086,477) $ (6,003,017)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on equity method investment 2,293,580
Depreciation and amortization 147,628 71,562
Vesting expense for stock options and warrants 1,124,928 2,298,680
Equity instruments issued for management and consulting 335,238 359,133
Amortization of debt discount 385,111
Gain from sale of marketable securities (1,837)
Gain on valuation of equity-linked instruments (372,263)
Changes in assets and liabilities:    
Accounts receivable (95,103) (98,580)
Inventories 23,979 7,163
Prepaid expense and other assets 139,895 (141,329)
Accounts payable 305,227 (79,650)
Accrued expenses 493,899 (870,540)
Deferred revenue 16,402 (1,335)
Net cash used in operating activities (5,287,956) (4,459,750)
Cash flow from investing activities:    
Proceeds from sale of marketable securities 284,665
Purchase of certificates of deposit (3,084,971)
Redemption of certificates of deposit 244,971 2,940,000
Advances on notes receivable (1,123,619) (1,737,512)
Purchase of fixed assets (177,732) (45,093)
Purchase of intangibles (54,271) (10,179)
Net cash used in investing activities (1,110,651) (1,653,090)
Cash flow from financing activities:    
Proceeds from exercise of warrants into common stock 650,061
Proceeds from debt issuance 2,185,000
Net proceeds from issuance of preferred stock 1,300,001
Proceeds from Issuance of Common Stock 2,959,509 3,814,938
Net cash provided by financing activities 5,794,570 5,114,939
Net decrease in cash (604,037) (997,901)
Cash at beginning of period 766,189 1,764,090
Cash at end of period 162,152 766,189
Non-cash transactions in investing and financing activities    
Conversion of preferred stock to common stock 6,479
Equity method investment – Helomics 1,542,250
Licensing Fee for Tumorgenesis [Member]    
Non-cash transactions in investing and financing activities    
Stock issued for fees $ 877,500